- Filed
- Apr 25, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2024 · Apr 22, 2024 | 92.79M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2024 | 93M sh |
| Shares Diluted | Q1 2024 · Mar 31, 2023 | 92.7M sh |
| Capex | Q1 2024 · Mar 31, 2024 | $43.1M |
| Capex | Q1 2024 · Mar 31, 2023 | $36.4M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2024 | −$54.5M |
| Operating Cash Flow | Q1 2024 · Mar 31, 2023 | $49.5M |
| Cash And Equivalents | Q1 2024 · Mar 31, 2024 | $31M |
| Cash And Equivalents | Q1 2024 · Dec 31, 2023 | $35.3M |
| Stockholders Equity | Q1 2024 · Mar 31, 2024 | $2.52B |
| Stockholders Equity | Q1 2024 · Dec 31, 2023 | $2.52B |
| Current Liabilities | Q1 2024 · Mar 31, 2024 | $654.9M |
| Current Liabilities | Q1 2024 · Dec 31, 2023 | $718M |
| Total Liabilities | Q1 2024 · Mar 31, 2024 | $2.91B |
| Total Liabilities | Q1 2024 · Dec 31, 2023 | $2.83B |
| Current Assets | Q1 2024 · Mar 31, 2024 | $728.8M |
| Current Assets | Q1 2024 · Dec 31, 2023 | $671.5M |
| Total Assets | Q1 2024 · Mar 31, 2024 | $5.44B |
| Total Assets | Q1 2024 · Dec 31, 2023 | $5.35B |
| Eps Diluted | Q1 2024 · Mar 31, 2024 | $0.14 |
| Eps Diluted | Q1 2024 · Mar 31, 2023 | $0.12 |
| Eps Basic | Q1 2024 · Mar 31, 2024 | $0.14 |
| Eps Basic | Q1 2024 · Mar 31, 2023 | $0.12 |
| Sga Expense | Q1 2024 · Mar 31, 2024 | $216M |
| Sga Expense | Q1 2024 · Mar 31, 2023 | $216M |
| Operating Income | Q1 2024 · Mar 31, 2024 | $38.9M |
| Operating Income | Q1 2024 · Mar 31, 2023 | $40M |
| Gross Profit | Q1 2024 · Mar 31, 2024 | $254.9M |
| Gross Profit | Q1 2024 · Mar 31, 2023 | $261M |
| Revenue | Q1 2024 · Mar 31, 2024 | $664.9M |
| Revenue | Q1 2024 · Mar 31, 2023 | $684.3M |